EGFR and breast neoplasm: Further, in addition to the subcutaneous implantation, we utilize syngeneic orthotopic implantation model to investigate the role of D-RF6 CPPP in suppresses breast tumor growth especially the therapeutic effect against EGFR TKI-resistant TNBC.